Rodent models of impulsive compulsive behaviors in Parkinson's disease: how far have we reached?
Cenci Nilsson, Angela LU
; Francardo, Veronica
LU
; O'Sullivan, Sean S
and Lindgren, Hanna
LU
(2015)
In Neurobiology of Disease
82(aug 29).
p.561-573
- Abstract
- There is increasing awareness that the medications used to treat the motor symptoms of Parkinson's disease (PD) contribute to the development of behavioral addictions, which have been clinically defined as impulsive compulsive behaviors (ICBs). These features include pathological gambling, compulsive sexual behavior, binge eating, compulsive shopping, excessive hobbyism or punding, and the excessive use of dopaminergic medication. ICBs frequently have devastating effects on the social and occupational function of the affected individuals as well as their families. Although ICBs are an important clinical problem in PD, the number of studies in which these symptoms have been modeled in rodents is still limited. This may depend on... (More)
- There is increasing awareness that the medications used to treat the motor symptoms of Parkinson's disease (PD) contribute to the development of behavioral addictions, which have been clinically defined as impulsive compulsive behaviors (ICBs). These features include pathological gambling, compulsive sexual behavior, binge eating, compulsive shopping, excessive hobbyism or punding, and the excessive use of dopaminergic medication. ICBs frequently have devastating effects on the social and occupational function of the affected individuals as well as their families. Although ICBs are an important clinical problem in PD, the number of studies in which these symptoms have been modeled in rodents is still limited. This may depend on uncertainties regarding, on one hand, the pathophysiology of these behaviors and, on the other hand, the experimental paradigms with which similar features can be induced in rodents. To help compose these uncertainties, we will here review the characteristics of ICBs in PD patients and then describe behavioral methods to approximate them in rodents. We will discuss both the challenges and the possibilities of applying these methods to animals with PD-like lesions, and review the recent progress made to this end. We will finally highlight important questions deserving further investigation. Rodent models having both face validity and construct validity to parkinsonian ICBs will be essential to further pathophysiological and therapeutic investigations into this important area. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/8043577
- author
- Cenci Nilsson, Angela
LU
; Francardo, Veronica
LU
; O'Sullivan, Sean S
and Lindgren, Hanna
LU
- organization
- publishing date
- 2015
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Neurobiology of Disease
- volume
- 82
- issue
- aug 29
- pages
- 561 - 573
- publisher
- Elsevier
- external identifiers
-
- pmid:26325219
- wos:000364980000053
- scopus:84946413608
- pmid:26325219
- ISSN
- 0969-9961
- DOI
- 10.1016/j.nbd.2015.08.026
- language
- English
- LU publication?
- yes
- id
- da5f687c-046e-40ef-9040-6e069a5c49c6 (old id 8043577)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26325219?dopt=Abstract
- date added to LUP
- 2016-04-01 09:50:36
- date last changed
- 2022-04-19 20:08:13
@article{da5f687c-046e-40ef-9040-6e069a5c49c6,
abstract = {{There is increasing awareness that the medications used to treat the motor symptoms of Parkinson's disease (PD) contribute to the development of behavioral addictions, which have been clinically defined as impulsive compulsive behaviors (ICBs). These features include pathological gambling, compulsive sexual behavior, binge eating, compulsive shopping, excessive hobbyism or punding, and the excessive use of dopaminergic medication. ICBs frequently have devastating effects on the social and occupational function of the affected individuals as well as their families. Although ICBs are an important clinical problem in PD, the number of studies in which these symptoms have been modeled in rodents is still limited. This may depend on uncertainties regarding, on one hand, the pathophysiology of these behaviors and, on the other hand, the experimental paradigms with which similar features can be induced in rodents. To help compose these uncertainties, we will here review the characteristics of ICBs in PD patients and then describe behavioral methods to approximate them in rodents. We will discuss both the challenges and the possibilities of applying these methods to animals with PD-like lesions, and review the recent progress made to this end. We will finally highlight important questions deserving further investigation. Rodent models having both face validity and construct validity to parkinsonian ICBs will be essential to further pathophysiological and therapeutic investigations into this important area.}},
author = {{Cenci Nilsson, Angela and Francardo, Veronica and O'Sullivan, Sean S and Lindgren, Hanna}},
issn = {{0969-9961}},
language = {{eng}},
number = {{aug 29}},
pages = {{561--573}},
publisher = {{Elsevier}},
series = {{Neurobiology of Disease}},
title = {{Rodent models of impulsive compulsive behaviors in Parkinson's disease: how far have we reached?}},
url = {{http://dx.doi.org/10.1016/j.nbd.2015.08.026}},
doi = {{10.1016/j.nbd.2015.08.026}},
volume = {{82}},
year = {{2015}},
}